Fairvalue-Calculator Fairvalue-Calculator
EN DE

Farmacias Benavides, S.A. (BEVIDESB) Fair Value & Analysis

Healthcare · MX · Market cap 10.6B MXN

Price26.00 MXN
Fair Value16.52 MXN
Upside-36.5%
Quality89/100
Evidence: Medium Range 12.39 MXN – 20.65 MXN

Fair value as of: Jun 24, 2026

Analysis

Farmacias Benavides, S.A. (BEVIDESB) currently trades at 26.00 MXN, while our model-based Fair Value estimate is 16.52 MXN — implying the stock looks roughly 36.5% overvalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Farmacias Benavides, S.A.B. de C.V. engages in the retail of health and wellness products. The company also provides medicamentos, non-perishable food, and hygiene and beauty products, as well as photography. The company was founded in 1917 and is based in Monterrey, Mexico. Farmacias Benavides, S.A.B. de C.V. operates as a subsidiary of Walgreens Boots Alliance, Inc.

Open the full interactive analysis →

Similar stocks

JD Health International Inc (JDHIF) +920% Alibaba Health Information Technology Limited (ALBBY) -19% Raia Drogasil S.A (RADL3) +21% Yifeng Pharmacy Chain Co (603939) +5% Clicks Group (CLCGY) +23% Sugi Holdings (SGIPF) +295%

Frequently asked questions

Is Farmacias Benavides, S.A. (BEVIDESB) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 16.52 MXN versus a price of 26.00 MXN — about −36% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BEVIDESB?
Our 21-model fair value for Farmacias Benavides, S.A. is 16.52 MXN (as of Jun 24, 2026), built from audited fundamentals. The current price is 26.00 MXN.
What is the quality score of BEVIDESB?
Farmacias Benavides, S.A. has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.